Aisling Capital Partners III LLC, 10% Owner at T2 Biosystems, Inc. (TTOO), bought 307,692 shares at $9.75 ($3.0M) on 2015-12-09, disclosed to the SEC on 2015-12-09.
Open-market purchase of $3.0M TTOO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| LOXO | BUY | 2016-05-19 | $5.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |
| LOXO | BUY | 2015-11-16 | $2.2M | — | Filing → |